[{"NetIncomeLoss_1_Q1_USD":-16126000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-109000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":8800000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":3141000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":5601000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":9920000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-31000.0,"PrepaidExpenseAndOtherAssetsNoncurrent_0_Q1_USD":2353000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":661000.0,"PrepaidExpenseAndOtherAssets_0_Q1_USD":4573000.0,"TemporaryEquitySharesOutstanding_0_Q1_shares":10817348.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":155934207.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":13424000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1044000.0,"Assets_0_Q1_USD":87629000.0,"ShareBasedCompensation_1_Q1_USD":329000.0,"AssetsCurrent_0_Q1_USD":66009000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2276000.0,"OperatingLeaseLiability_0_Q1_USD":2294000.0,"Liabilities_0_Q1_USD":20886000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":13258000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":2657000.0,"TemporaryEquityLiquidationPreference_0_Q1_USD":162120310.0,"TemporaryEquityAggregateAmountOfRedemptionRequirement_0_Q1_USD":162120000.0,"MinorityInterest_0_Q1_USD":6712000.0,"PaymentsOfFinancingCosts_1_Q1_USD":754000.0,"TemporaryEquitySharesAuthorized_0_Q1_shares":10817348.0,"DeferredCosts_0_Q1_USD":3525000.0,"AccountsReceivableNetCurrent_0_Q1_USD":139000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":53000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":38000.0,"TemporaryEquitySharesIssued_0_Q1_shares":10817348.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":13474000.0,"RestrictedCash_0_Q1_USD":411000.0,"TemporaryEquityStockIssuedDuringPeriodValueNewIssues_1_Q1_USD":14228000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":63650000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":765000.0,"ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_1_Q1_USD":14228000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":187000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":205000.0,"Goodwill_0_Q1_USD":3736000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-16235000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":329000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-16871000.0,"LiabilitiesCurrent_0_Q1_USD":16939000.0,"AccountsPayableCurrent_0_Q1_USD":7019000.0,"RestrictedCashNoncurrent_0_Q1_USD":411000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":64061000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":83000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":-89191000.0,"MembersEquity_0_Q1_USD":-95903000.0,"PrepaidInsurance_0_Q1_USD":303000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":2463000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":25000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":519000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2220000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":363000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-1000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-99119000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1050000.0,"OperatingIncomeLoss_1_Q1_USD":-16399000.0,"OtherNonoperatingExpense_1_Q1_USD":0.0,"InvestmentIncomeInterest_1_Q1_USD":164000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":87629000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2008000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":329000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-3428000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":724000.0,"OperatingExpenses_1_Q1_USD":16399000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.88,"ProfitLoss_1_Q1_USD":-16235000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1484000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":31000.0,"MembersEquityAttributableToNoncontrollingInterest_0_Q1_USD":6712000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":810000.0,"LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":-89191000.0,"Ticker":"ZNTL","CIK":"1725160","name":"ZENTALIS PHARMACEUTICALS, INC.","OfficialName":"Zentalis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1133146413.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20200515"}]